Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination
Animal Models and Experimental Medicine · 16.11.2026
DOI: 10.1002/ame2.70296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 16.11.2026. Verfasst von Fatemeh Taghizadeh und 5 weiteren Autor:innen. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Changes in the microenvironment surrounding oligodendrocyte progenitor cells (OPCs), characterized by excessive production of extracellular matrix (ECM) components driven by elevated TGF‐β and CTGF signaling, impair the remyelination capacity of these cells. Decorin (DCN), an endogenous inhibitor of the TGF‐β/CTGF signaling axis, has emerged as a potential regulator of ECM homeostasis.
Methods
To improve the therapeutic outcomes of stem cell‐based strategies, adipose‐derived mesenchymal stem cells (ADMSCs) were preconditioned with metformin (MET) before transplantation into a C57BL/6 mouse model of cuprizone‐induced demyelination. Cell viability and the expression of CXCR4 and SDF‐1α were evaluated to determine the migratory potential following MET preconditioning. Remyelination and oligodendroglial lineage dynamics were assessed using Luxol Fast Blue (LFB) staining and analysis of MBP and NG2 expression. ECM remodeling and mechanosensitive signaling were evaluated through the expression of DCN, TGF‐β, CTGF, and Piezo 1.
Results
MET preconditioning was optimized at 1 mmol/L for 24 h based on MTT assay results and increased the migratory potential of ADMSCs, as indicated by upregulation of the CXCR4/SDF‐1α axis. Histological analysis revealed enhanced remyelination, accompanied by increased MBP and reduced NG2 expression in treated groups. At the molecular level, transplantation of MET‐preconditioned ADMSCs upregulated DCN while downregulating TGF‐β, CTGF, and Piezo 1 expression.
Conclusion
MET preconditioning enhances the therapeutic efficacy of ADMSCs through increasing migration and homing of these cells and consequently promotes remyelination in a cuprizone‐induced demyelination model, potentially through DCN‐mediated mechanisms.
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Taghizadeh, F., Pasbakhsh, P., Alikarami, A., Noorzehi, G., Mojaverrostami, S., & Kashani, I. R. (2026). Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70296
Vancouver
Taghizadeh F, Pasbakhsh P, Alikarami A, Noorzehi G, Mojaverrostami S, Kashani IR. Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70296
BibTeX
@article{Taghizadeh2026,
author = {Taghizadeh, Fatemeh and Pasbakhsh, Parichehr and Alikarami, Ameneh and Noorzehi, Golaleh and Mojaverrostami, Sina and Kashani, Iraj Ragerdi},
title = {Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination},
journal = {Animal Models and Experimental Medicine},
year = {2026},
doi = {10.1002/ame2.70296}
}
EUVIMED